Sfoglia per Autore
2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde
2021-01-01 Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San
Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll
2021-01-01 Vitale C.; Griggio V.; Riganti C.; Todaro M.; Kopecka J.; Jones R.; Salvetti C.; Boccellato E.; Perutelli F.; Voena C.; Godio L.; Boccadoro M.; Coscia M.
Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs
2021-01-01 Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia
Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial
2021-01-01 Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario
Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group
2021-01-01 Moreau P.; Kumar S.K.; San Miguel J.; Davies F.; Zamagni E.; Bahlis N.; Ludwig H.; Mikhael J.; Terpos E.; Schjesvold F.; Martin T.; Yong K.; Durie B.G.M.; Facon T.; Jurczyszyn A.; Sidana S.; Raje N.; van de Donk N.; Lonial S.; Cavo M.; Kristinsson S.Y.; Lentzsch S.; Hajek R.; Anderson K.C.; Joao C.; Einsele H.; Sonneveld P.; Engelhardt M.; Fonseca R.; Vangsted A.; Weisel K.; Baz R.; Hungria V.; Berdeja J.G.; Leal da Costa F.; Maiolino A.; Waage A.; Vesole D.H.; Ocio E.M.; Quach H.; Driessen C.; Blade J.; Leleu X.; Riva E.; Bergsagel P.L.; Hou J.; Chng W.J.; Mellqvist U.-H.; Dytfeld D.; Harousseau J.-L.; Goldschmidt H.; Laubach J.; Munshi N.C.; Gay F.; Beksac M.; Costa L.J.; Kaiser M.; Hari P.; Boccadoro M.; Usmani S.Z.; Zweegman S.; Holstein S.; Sezer O.; Harrison S.; Nahi H.; Cook G.; Mateos M.-V.; Rajkumar S.V.; Dimopoulos M.A.; Richardson P.G.
Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
2021-01-01 Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele
Gammopatie monoclonali
2020-01-01 Chiara Cerrato, Roberto Mina, Mario Boccadoro
Therapeutic monoclonal antibodies and antibody products: Current practices and development in multiple myeloma
2020-01-01 Bonello F.; Mina R.; Boccadoro M.; Gay F.
Droplet Digital PCR Assay for MYD88L265P
2020-01-01 Lo Schirico, Mariella; Ferrante, Martina; Dogliotti, Irene; Zamò, Alberto; Ferrero, Bruno; Bertuzzo, Davide; Benevolo, Giulia; Omedè, Paola; Cavallo, Federica; Ladetto, Marco; Boccadoro, Mario; Drandi, Daniela; Ferrero, Simone
Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia
2020-01-01 Cerrano M.; Castella B.; Lia G.; Olivi M.; Faraci D.G.; Butera S.; Martella F.; Scaldaferri M.; Cattel F.; Boccadoro M.; Massaia M.; Ferrero D.; Bruno B.; Giaccone L.
Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells
2020-01-01 Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M.
Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia
2020-01-01 Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, Coscia M
Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma
2020-01-01 Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A.
Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents
2020-01-01 Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A.
Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study
2020-01-01 Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P.
Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study
2020-01-01 Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A.
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs
2020-01-01 Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M.
Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)
2020-01-01 Terpos E.; Engelhardt M.; Cook G.; Gay F.; Mateos M.-V.; Ntanasis-Stathopoulos I.; van de Donk N.W.C.J.; Avet-Loiseau H.; Hajek R.; Vangsted A.J.; Ludwig H.; Zweegman S.; Moreau P.; Einsele H.; Boccadoro M.; San Miguel J.; Dimopoulos M.A.; Sonneveld P.
Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation
2020-01-01 Apolito V.; Giaccone L.; Ferrero S.; Larocca A.; Cavallo F.; Coscia M.; Beggiato E.; Butera S.; Martella F.; Dainese C.; Cetani G.; Scaldaferri M.; Cattel F.; Boccadoro M.; Ferrero D.; Bruno B.; Cerrano M.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 2021 European Myeloma Network review and consensus statement on smoldering multiple myeloma: how to distinguish (and manage) Dr. Jekyll and Mr. Hyde | 2021 | Musto, Pellegrino; Engelhardt, Monika; Caers, Jo; Bolli, Niccolo'; Kaiser, Martin; Van de Donk, Niels; Terpos, Evangelos; Broijl, Annemiek; De Larrea, Carlos Fernández; Gay, Francesca; Goldschmidt, Hartmut; Hajek, Roman; Vangsted, Annette Juul; Zamagni, Elena; Zweegman, Sonja; Cavo, Michele; Dimopoulos, Meletios; Einsele, Hermann; Ludwig, Heinz; Barosi, Giovanni; Boccadoro, Mario; Mateos, Maria-Victoria; Sonneveld, Pieter; Miguel, Jesus San | |
| Targeting hif-1α regulatory pathways as a strategy to hamper tumor-microenvironment interactions in cll | 2021 | Vitale C.; Griggio V.; Riganti C.; Todaro M.; Kopecka J.; Jones R.; Salvetti C.; Boccellato E.; Perutelli F.; Voena C.; Godio L.; Boccadoro M.; Coscia M. | |
| Pre-existing and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs | 2021 | Candida Vitale, Chiara Salvetti, Valentina Griggio, Marika Porrazzo, Luana Schiattone, Giulia Zamprogna, Andrea Visentin, Francesco Vassallo, Ramona Cassin, Gian Matteo Rigolin, Roberta Murru, Luca Laurenti, Paolo Rivela, Monia Marchetti, Elsa Pennese, Massimo Gentile, Elia Boccellato, Francesca Perutelli, Maria Chiara Montalbano, Lorenzo De Paoli, Gianluigi Reda, Lorella Orsucci, Livio Trentin, Antonio Cuneo, Alessandra Tedeschi, Lydia Scarfò, Gianluca Gaidano, Francesca Romana Mauro, Robin Foà, Mario Boccadoro, Marta Coscia | |
| Carfilzomib with cyclophosphamide and dexamethasone or lenalidomide and dexamethasone plus autologous transplantation or carfilzomib plus lenalidomide and dexamethasone, followed by maintenance with carfilzomib plus lenalidomide or lenalidomide alone for patients with newly diagnosed multiple myeloma (FORTE): a randomised, open-label, phase 2 trial | 2021 | Gay, Francesca; Musto, Pellegrino; Rota-Scalabrini, Delia; Bertamini, Luca; Belotti, Angelo; Galli, Monica; Offidani, Massimo; Zamagni, Elena; Ledda, Antonio; Grasso, Mariella; Ballanti, Stelvio; Spadano, Antonio; Cea, Michele; Patriarca, Francesca; D'Agostino, Mattia; Capra, Andrea; Giuliani, Nicola; de Fabritiis, Paolo; Aquino, Sara; Palmas, Angelo; Gamberi, Barbara; Zambello, Renato; Petrucci, Maria Teresa; Corradini, Paolo; Cavo, Michele; Boccadoro, Mario | |
| Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group | 2021 | Moreau P.; Kumar S.K.; San Miguel J.; Davies F.; Zamagni E.; Bahlis N.; Ludwig H.; Mikhael J.; Terpos E.; Schjesvold F.; Martin T.; Yong K.; Durie B.G.M.; Facon T.; Jurczyszyn A.; Sidana S.; Raje N.; van de Donk N.; Lonial S.; Cavo M.; Kristinsson S.Y.; Lentzsch S.; Hajek R.; Anderson K.C.; Joao C.; Einsele H.; Sonneveld P.; Engelhardt M.; Fonseca R.; Vangsted A.; Weisel K.; Baz R.; Hungria V.; Berdeja J.G.; Leal da Costa F.; Maiolino A.; Waage A.; Vesole D.H.; Ocio E.M.; Quach H.; Driessen C.; Blade J.; Leleu X.; Riva E.; Bergsagel P.L.; Hou J.; Chng W.J.; Mellqvist U.-H.; Dytfeld D.; Harousseau J.-L.; Goldschmidt H.; Laubach J.; Munshi N.C.; Gay F.; Beksac M.; Costa L.J.; Kaiser M.; Hari P.; Boccadoro M.; Usmani S.Z.; Zweegman S.; Holstein S.; Sezer O.; Harrison S.; Nahi H.; Cook G.; Mateos M.-V.; Rajkumar S.V.; Dimopoulos M.A.; Richardson P.G. | |
| Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma | 2021 | Sonneveld, Pieter; Dimopoulos, Meletios A; Beksac, Meral; van der Holt, Bronno; Aquino, Sara; Ludwig, Heinz; Zweegman, Sonja; Zander, Thilo; Zamagni, Elena; Wester, Ruth; Hajek, Roman; Pantani, Lucia; Dozza, Luca; Gay, Francesca; Cafro, AnneMaria; De Rosa, Luca; Morelli, Annamaria; Gregersen, Henrik; Gulbrandsen, Nina; Cornelisse, Petra; Troia, Rosella; Oliva, Stefania; van de Velden, Vincent; Wu, KaLung; Ypma, Paula F; Bos, Gerard; Levin, Mark-David; Pour, Luca; Driessen, Christoph; Broijl, Annemiek; Croockewit, Alexandra; Minnema, Monique C; Waage, Anders; Hveding, Cecilie; van de Donk, Niels W C J; Offidani, Massimo; Palumbo, Giuseppe A; Spencer, Andrew; Boccadoro, Mario; Cavo, Michele | |
| Gammopatie monoclonali | 2020 | Chiara Cerrato, Roberto Mina, Mario Boccadoro | |
| Therapeutic monoclonal antibodies and antibody products: Current practices and development in multiple myeloma | 2020 | Bonello F.; Mina R.; Boccadoro M.; Gay F. | |
| Droplet Digital PCR Assay for MYD88L265P | 2020 | Lo Schirico, Mariella; Ferrante, Martina; Dogliotti, Irene; Zamò, Alberto; Ferrero, Bruno; Bertuzzo, Davide; Benevolo, Giulia; Omedè, Paola; Cavallo, Federica; Ladetto, Marco; Boccadoro, Mario; Drandi, Daniela; Ferrero, Simone | |
| Immunomodulatory and clinical effects of daratumumab in T-cell acute lymphoblastic leukaemia | 2020 | Cerrano M.; Castella B.; Lia G.; Olivi M.; Faraci D.G.; Butera S.; Martella F.; Scaldaferri M.; Cattel F.; Boccadoro M.; Massaia M.; Ferrero D.; Bruno B.; Giaccone L. | |
| Evaluation of the cytotoxic effect of selinexor in combination with chemotherapy or idelalisib towards primary CLL cells | 2020 | Vitale C, Todaro M, Griggio V, Salvetti C, Riganti C, Landesman Y, Boccadoro M, Coscia M. | |
| Immune dysfunctions and immune-based therapeutic interventions in chronic lymphocytic leukemia | 2020 | Griggio V, Perutelli F, Salvetti C, Boccellato E, Boccadoro M, Vitale C, Coscia M | |
| Clinical Applications and Future Directions of Minimal Residual Disease Testing in Multiple Myeloma | 2020 | Oliva S.; D'Agostino M.; Boccadoro M.; Larocca A. | |
| Clinical features and survival of multiple myeloma patients harboring t(14;16) in the era of novel agents | 2020 | Mina R.; Joseph N.S.; Gay F.; Kastritis E.; Petrucci M.T.; Kaufman J.L.; Montefusco V.; Gavriatopoulou M.; Patriarca F.; Omede P.; Boise L.H.; Roussou M.; Giuliani N.; Oliva S.; Offidani M.; Belotti A.; Jaye D.L.; De Paoli L.; Terpos E.; Lonial S.; Boccadoro M.; Nooka A.K.; Dimopoulos M.A. | |
| Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study | 2020 | Cavo M.; Gay F.; Beksac M.; Pantani L.; Petrucci M.T.; Dimopoulos M.A.; Dozza L.; van der Holt B.; Zweegman S.; Oliva S.; van der Velden V.H.J.; Zamagni E.; Palumbo G.A.; Patriarca F.; Montefusco V.; Galli M.; Maisnar V.; Gamberi B.; Hansson M.; Belotti A.; Pour L.; Ypma P.; Grasso M.; Croockewit A.; Ballanti S.; Offidani M.; Vincelli I.D.; Zambello R.; Liberati A.M.; Andersen N.F.; Broijl A.; Troia R.; Pascarella A.; Benevolo G.; Levin M.-D.; Bos G.; Ludwig H.; Aquino S.; Morelli A.M.; Wu K.L.; Boersma R.; Hajek R.; Durian M.; von dem Borne P.A.; Caravita di Toritto T.; Zander T.; Specchia G.; Waage A.; Gimsing P.; Mellqvist U.-H.; van Marwijk Kooy M.; Minnema M.; Mandigers C.; Cafro A.M.; Palmas A.; Carvalho S.; Spencer A.; Boccadoro M.; Sonneveld P. | |
| Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study | 2020 | Mina R.; Belotti A.; Petrucci M.T.; Zambello R.; Capra A.; Di Lullo G.; Ronconi S.; Pescosta N.; Grasso M.; Monaco F.; Cellini C.; Gobbi M.; Ballanti S.; de Fabritiis P.; Mosca-Siez M.L.; Marchetti M.; Liberati A.M.; Offidani M.; Giuliani N.; Ria R.; Musto P.; Romano A.; Sonneveld P.; Boccadoro M.; Larocca A. | |
| Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
| Outcome of paraosseous extra-medullary disease in newly diagnosed multiple myeloma patients treated with new drugs | 2020 | Montefusco V.; Gay F.; Spada S.; de Paoli L.; Raimondo F.D.; Ribolla R.; Musolino C.; Patriarca F.; Musto P.; Galieni P.; Ballanti S.; Nozzoli C.; Cascavilla N.; Ben-Yehuda D.; Nagler A.; Hajek R.; Offidani M.; Liberati A.M.; Sonneveld P.; Cavo M.; Corradini P.; Boccadoro M. | |
| Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN) | 2020 | Terpos E.; Engelhardt M.; Cook G.; Gay F.; Mateos M.-V.; Ntanasis-Stathopoulos I.; van de Donk N.W.C.J.; Avet-Loiseau H.; Hajek R.; Vangsted A.J.; Ludwig H.; Zweegman S.; Moreau P.; Einsele H.; Boccadoro M.; San Miguel J.; Dimopoulos M.A.; Sonneveld P. | |
| Netupitant-palonosetron to prevent chemotherapy-induced nausea and vomiting in multiple myeloma patients receiving high-dose melphalan and autologous stem cell transplantation | 2020 | Apolito V.; Giaccone L.; Ferrero S.; Larocca A.; Cavallo F.; Coscia M.; Beggiato E.; Butera S.; Martella F.; Dainese C.; Cetani G.; Scaldaferri M.; Cattel F.; Boccadoro M.; Ferrero D.; Bruno B.; Cerrano M. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile